expect momentum slow reiter ow
invest summari reiter overweight rate share
maintain price target momentum continu compani
significantli beat metric track deliv procedur growth
highest quarterli procedur growth sinc rais
full-year procedur growth guidanc global
instal base grew util mid-singl digit strong
quarterli growth expand number futur growth driver continu justifi
premium valuat view
 continu adopt across number procedur demonstr robot
surgeri momentum deliv procedur growth
significantli beat street expect driven strength us
gener surgeri urolog procedur outsid us us procedur growth
driven gener surgeri specif hernia repair
colorect continu better-than-expect growth matur procedur
ou procedur growth larg driven urolog procedur
procedur growth japan sign start see
benefit addit cover procedur
first sp system sold submit second sp indic tor fda
sold first three da vinci sp system quarter first site
focu clinic data gener custom feedback manag still
expect measur launch sp next quarter team collect
data ensur custom satisfact submit next sp indic
transor tor fda clearanc
posit first impress ion showcas ion flexibl robot
platform chest confer earlier octob said physician
feedback posit rel compet product recal
submit fda clearanc august work toward clearanc
readi ion first phase launch
 rais estim rais sale estim
respect also
rais ep estim
respect
 valuat price target base price-to-earnings multipl
ep estim believ compani top-lin growth profil build
momentum justifi premium
disclosur section may found page
sourc compani document factset cantor fitzgerald estim
exhibit comparison cantor estim
compani document cantor fitzgerald estim
intuit surgic million except per dilut surgic million except per share current priorcurr priorp incom net tax dilut octob
price target base price-to-earnings multipl ep estim think premium
rel peer justifi given compani top-lin growth profil double-digit vs peer median
growth mid-singl digit build momentum robot surgeri pipelin
significantli expand address market
competit larger smaller compani first receiv clearanc surgic robot
virtual competit sinc coupl robot smaller compani
receiv fda clearanc specif type procedur past fall trxc cover
senhanc second multi-port system receiv fda clearanc cover
cover world-wide leader gener surgeri work develop
robot more-signific risk pose threat
long-stand relationship hospit global may abl offer discount packag
equip entic hospit purchas robot although delay expect
time robot launch expect market robot within next year
enter joint ventur call verb surgic googl develop surgic robot
believ year away potenti launch
matur procedur growth averag earli success primarili driven
prostatectomi hysterectomi procedur combin repres approxim
total procedur procedur like close highest level
penetr prostatectomi becom standard care us believ hysterectomi
settl signific penetr like experi expect
growth two procedur significantli higher low-single-digit incid rate
procedur slow below-market growth could neg affect isrg overal
procedur growth given proport overal procedur matur procedur repres
capit equip environ volatil revenu repres isrg revenu
meaning portion isrg overal revenu purchas robot signific capit
expenditur hospit econom slowdown potenti requir spend hospit could
limit compani abil desir make larg capit equip purchas could affect
abil sell system also expand addit intern market chang
polit environ could limit amount capit avail foreign hospit spend
compani document cantor fitzgerald research
intuit surgic inc quarterli incom statement million except per share data fiscal year end decemb instrument servic total good sold excl sbc gross profit ex sbc sg excl sbc excl sbc oper expens excl sbc oper incom excl sbc interest incom net incom tax excl sbc incom tax adjust net non-control adjust net incom fulli dilut adjust adjust adjust margin excl sbc amort good profit expens incom incom excl sbc amort growthtot good profit ex sbc oper incom excl sbc incom net tax incom excl sbc dilut octob
intuit surgic inc intuit design manufactur market da vinci surgic system relat instrument accessori
compani da vinci surgic system consist surgeon consol patient-sid cart vision system da vinci surgic system
translat surgeon hand movement perform instrument control consol correspond micro-mov
instrument posit insid patient small incis port da vinci surgic system provid oper surgeon
control rang motion tissu manipul capabl three-dimension high-definit hd vision intuit five
gener da vinci surgic system da vinci surgic system da vinci xi surgic system da vinci si surgic system
da vinci surgic system standard da vinci surgic system compani instrument accessori includ endowrist
instrument da vinci single-sit
analyst primarili respons research report whose name appear front cover certifi view express
research report accur reflect person view subject secur issuer featur report ii part
research analyst compens directli indirectli relat specif recommend view express
research analyst report
